TAOK3 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance Through Augmenting Autophagy Mediated by IRGM. Sun, M., Li, Z., Wang, X., Zhao, M., Chu, Y., Zhang, Z., Fang, K., Zhao, Z., Feng, A., Leng, Z., Shi, J., Zhang, L., Chen, T., & Xu, M. Advanced Science, 10(29):2300864, October, 2023.
TAOK3 Facilitates Esophageal Squamous Cell Carcinoma Progression and Cisplatin Resistance Through Augmenting Autophagy Mediated by IRGM [link]Paper  doi  abstract   bibtex   
Abstract Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers because of its robust aggressive phenotype and chemoresistance. TAO kinase belongs to mitogen‐activated protein kinases, which mediate drug resistance in multiple cancers. However, the role of TAO kinase in ESCC progression and chemoresistance has never been explored. Here, it is reported that TAOK3 augments cell autophagy and further promotes ESCC progression and chemoresistance. Mechanistically, TAOK3 phosphorylates KMT2C at S4588 and strengthens the interaction between KMT2C and ETV5. Consequently, the nuclear translocation of KMT2C is increased, and the transcription of autophagy‐relevant gene IRGM is further upregulated. Additionally, the inhibitor SBI‐581 can significantly suppress cell autophagy mediated by TAOK3 and synergizes with cisplatin to treat ESCC in vitro and in vivo.
@article{sun_taok3_2023,
	title = {{TAOK3} {Facilitates} {Esophageal} {Squamous} {Cell} {Carcinoma} {Progression} and {Cisplatin} {Resistance} {Through} {Augmenting} {Autophagy} {Mediated} by {IRGM}},
	volume = {10},
	issn = {2198-3844, 2198-3844},
	url = {https://onlinelibrary.wiley.com/doi/10.1002/advs.202300864},
	doi = {10.1002/advs.202300864},
	abstract = {Abstract
            Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers because of its robust aggressive phenotype and chemoresistance. TAO kinase belongs to mitogen‐activated protein kinases, which mediate drug resistance in multiple cancers. However, the role of TAO kinase in ESCC progression and chemoresistance has never been explored. Here, it is reported that TAOK3 augments cell autophagy and further promotes ESCC progression and chemoresistance. Mechanistically, TAOK3 phosphorylates KMT2C at S4588 and strengthens the interaction between KMT2C and ETV5. Consequently, the nuclear translocation of KMT2C is increased, and the transcription of autophagy‐relevant gene IRGM is further upregulated. Additionally, the inhibitor SBI‐581 can significantly suppress cell autophagy mediated by TAOK3 and synergizes with cisplatin to treat ESCC in vitro and in vivo.},
	language = {en},
	number = {29},
	urldate = {2024-08-15},
	journal = {Advanced Science},
	author = {Sun, Mingchuang and Li, Zhaoxing and Wang, Xiaoyuan and Zhao, Meirong and Chu, Yuan and Zhang, Zehua and Fang, Kang and Zhao, Ziying and Feng, Anqi and Leng, Zhuyun and Shi, Jianing and Zhang, Li and Chen, Tao and Xu, Meidong},
	month = oct,
	year = {2023},
	pages = {2300864},
}

Downloads: 0